Publication | Closed Access

Single- and Multiple-Dose Pharmacokinetic, Safety, and Tolerability Profiles of Olanzapine Long-Acting Injection: An Open-Label, Multicenter, Nonrandomized Study in Patients With Schizophrenia

Olanzapine Long-acting InjectionPsychiatryPsychotic DisorderAddictionMedicinePsychotropic MedicationPsychopharmacologySchizophreniaTolerability ProfilesMultiple-dose PharmacokineticPharmacotherapySocial SciencesPharmacologyPsychopathology